Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Idiopathic Orbital Inflammation Masquerading as Relapse of Seronegative Juvenile Myasthenia Gravis: A Case Report.

Journal of paediatrics and child health·2026

Same journal

Atomoxetine-Associated Remission of Giggle Incontinence in a Child With Attention-Deficit/Hyperactivity Disorder.

Journal of paediatrics and child health·2026

Same journal

Australian Guideline for the Identification and Management of Hypertension in Children and Adolescents.

Journal of paediatrics and child health·2026

Same journal

Chronic Urinary Tract Infection in Children: An Urgent Need for Recognition and Advocacy.

Journal of paediatrics and child health·2026

Same journal

Artificial Intelligence in Neonatal Care: The Breadth of Promise, the Depth of Challenge-An Overview.

Journal of paediatrics and child health·2026

Same journal

Prenatal Presentation of Congenital Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins: A Case Initially Suspected as Posterior Urethral Valves.

Journal of paediatrics and child health·2026

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Acute suicidality after commencing atomoxetine.

Georgia Armat Paxton¹, Noel Edward Cranswick

¹Department of General Paediatrics, Royal Children's Hospital, Flemington Road, Parkville, Victoria, Australia. georgia.paxton@rch.org.au

Journal of Paediatrics and Child Health

|November 18, 2008

Summary

Atomoxetine initiation in an 11-year-old boy led to acute agitation and suicidal ideation. This case underscores the need for careful monitoring of newly approved medications like atomoxetine.

More Related Videos

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Related Experiment Videos

Last Updated: Jun 27, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Area of Science:

Pediatric Psychiatry
Pharmacovigilance
Neuroscience

Background:

Atomoxetine, a selective norepinephrine reuptake inhibitor, was recently approved.
Selective serotonin reuptake inhibitors (SSRIs) are known to have potential psychiatric side effects.

Observation:

An 11-year-old boy experienced acute agitation and suicidal ideation shortly after starting atomoxetine.
The patient's symptoms resembled those seen with SSRI treatment.

Findings:

This case report details a potential adverse psychiatric event associated with atomoxetine.
The observed clinical features were analogous to known SSRI-induced behavioral changes.

Implications:

Highlights the critical need for close patient monitoring during the initiation of newly registered medications.
Suggests a potential class effect or shared mechanism for certain psychiatric adverse events with reuptake inhibitors.
Emphasizes the importance of reporting rare but severe adverse events in pharmacovigilance.